SunWay Biotech Co (ROCO:1271) Marketable Securities: NT$0.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:1271 SunWay Biotech Co Ltd ROCO:1271
91 GF Score
Price NT$60.90
GF Value NT$70.67
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is SunWay Biotech Co Marketable Securities?

SunWay Biotech Co ROCO:1271 +0.66% 91 Marketable Securities is NT$0.0 Mil as of Dec. 2025. GuruFocus rates ROCO:1271 with a GF Score™ of 91/100 and a GF Value™ of NT$70.67 (Modestly Undervalued). The stock has 8 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. SunWay Biotech Co's Marketable Securities for the quarter that ended in Dec. 2025 was NT$0.0 Mil.

SunWay Biotech Co  (ROCO:1271) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

SunWay Biotech Co Marketable Securities Related Terms

SunWay Biotech Co Marketable Securities Historical Data

* Premium members only.

The historical data trend for SunWay Biotech Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SunWay Biotech Co Marketable Securities Chart

SunWay Biotech Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

SunWay Biotech Co Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ROCO:1271
91GF Score
SunWay Biotech Co Ltd ROCO:1271
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SunWay Biotech Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of NT$0.0 Mil mean?
SunWay Biotech Co (ROCO:1271) has a Marketable Securities of NT$0.0 Mil as of Dec. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on SunWay Biotech Co and its competitors.
Is SunWay Biotech Co's Marketable Securities too high?
SunWay Biotech Co's current Marketable Securities is NT$0.0 Mil. Overall, SunWay Biotech Co has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SunWay Biotech Co's Marketable Securities compare to KHC and GIS?
SunWay Biotech Co's Marketable Securities of NT$0.0 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Consumer Packaged Goods company?
A good Marketable Securities depends on the Consumer Packaged Goods industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on SunWay Biotech Co and its competitors. SunWay Biotech Co's current Marketable Securities is NT$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SunWay Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, SunWay Biotech Co (ROCO:1271) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$70.67, compared to a current price of NT$60.90 — trading 13.8% below its estimated fair value. The current Marketable Securities is NT$0.0 Mil. SunWay Biotech Co's overall GF Score™ is 91/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For SunWay Biotech Co (ROCO:1271), the current Marketable Securities is NT$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SunWay Biotech Co (ROCO:1271) Overvalued in 2026?

Based on GuruFocus' analysis, SunWay Biotech Co stock appears to be undervalued. The current stock price of NT$60.90 is trading 13.8% below its estimated GF Value™ of NT$70.67. GuruFocus considers SunWay Biotech Co to be Modestly Undervalued.

Key valuation signals for ROCO:1271:

  • Marketable Securities: NT$0.0 Mil
  • GF Value™: NT$70.67 vs. price of NT$60.90 (13.8% below fair value)
  • GF Score™: 91/100 with 8 warning signs

No single metric tells the full story. See the ROCO:1271 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SunWay Biotech Co Business Description

Address No. 139, Xing’ai Road, Neihu District, Taipei, TWN, 11494
SunWay Biotech Co Ltd is engaged in the research, design and manufacturing of Monascus purpureus NTU 568, Lactobacillus paracasei subsp, paracasei NTU 101, and the related products.
91GF Score

Get the complete analysis for ROCO:1271

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$60.90
Price
NT$70.67
GF Value